CellCrine

Chemically Defined Media

A youthful protein* and an optimal Basal media outperforms FBS across all cell types tested to date

* Identified, Isolated, and sequenced

Patent Pending CC Tech

BAP Chemically Defined Supplement (BAP-CDS) that outperforms Fetal Bovine Serum (FBS).

CellCrine’s BAP CDS validated across many cell types including cell lines and primary cells

As the biopharmaceutical, cell therapy, and regenerative medicine sectors continue to expand, the demand for high-quality, consistent, and scalable culture media has become increasingly critical to emerging trends in laboratory automation, and sustainability.‍ ‍

BAP-CDS has been validated on more than 20 different cell types, including MSCs, Skin cells, Chondrocytes from human and other species, Tuna cells, CHO, MDCK, MRC5, HeLa, HEK293, Bovine adipocytes, muscle cells and fibroblasts, Porcine adipocytes, muscle cells and fibroblasts, Chicken muscle cells, adipocytes and fibroblasts, Stem cells, Vero, CEF/DF1, and iBSC.

Cracking the code

CellCrine’s BAP-CDS a significant milestone following 30 years of dedicated research and development.

BAP Chemically Defined Supplement (BAP-CDS) technology that consistently outperforms Fetal Bovine Serum (FBS).

CellCrine’s BAP-CDS allows cells to be seeded in scaffolds and standard cell culture-grade vessels.

For more information, please contact us at: info@cellcrine.com.